Subcutaneous immunoglobulin treatment and thromboembolic risk

Ann Allergy Asthma Immunol. 2018 Apr;120(4):433-435. doi: 10.1016/j.anai.2018.01.013. Epub 2018 Feb 2.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Humans
  • Immunoglobulins / administration & dosage*
  • Injections, Subcutaneous
  • Male
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / therapy*
  • Risk
  • Thromboembolism

Substances

  • Immunoglobulins